In 2022, CMS reported over $12.59 billion in payments from drug and device manufacturers to physicians and teaching hospitals through the Open Payments database — all publicly searchable. For healthcare organizations navigating both the US Sunshine Act and HIPAA, this level of transparency creates a compliance tension that few administrators fully appreciate. The question isn't whether these two frameworks overlap — it's how to manage the overlap without exposing your organization to enforcement risk on either side.

What the US Sunshine Act Requires from Healthcare Organizations

The US Sunshine Act, formally known as Section 6002 of the Affordable Care Act, requires applicable manufacturers and group purchasing organizations (GPOs) to report payments and transfers of value made to physicians and teaching hospitals. CMS publishes this data annually through its Open Payments program.

If your covered entity is a teaching hospital, you have a direct reporting obligation. Applicable manufacturers must report research payments, consulting fees, food and beverage costs, travel reimbursements, royalties, and ownership interests. Failure to report accurately can result in civil monetary penalties of up to $150,000 per incident, capped at $1 million annually.

But here's where it gets complicated for HIPAA-regulated entities: the data flowing between manufacturers, hospitals, and CMS can brush up against protected health information in ways your compliance team may not anticipate.

Where the US Sunshine Act Intersects with HIPAA Privacy Protections

Open Payments data doesn't typically include patient-level information. Manufacturer reports identify the physician, the nature of the payment, and the associated product — not the patient. On its surface, this seems cleanly separated from PHI.

In practice, the separation isn't always so clean. Research payment disclosures tied to clinical trials can, when combined with other publicly available information, narrow down patient populations. Teaching hospitals coordinating Sunshine Act reporting internally may circulate documents that reference both physician payment data and patient encounter details in the same workflows.

The Privacy Rule at 45 CFR §164.502(b) establishes the minimum necessary standard: your organization must make reasonable efforts to limit PHI use and disclosure to only what is needed for a particular purpose. When your compliance or finance teams compile Sunshine Act reports, they should never access or transmit protected health information that isn't directly required for the reporting obligation.

Business Associate Agreements and Third-Party Reporting Vendors

Many covered entities use third-party vendors to aggregate, validate, and submit Open Payments data. If those vendors handle any information that could constitute PHI — even indirectly — they qualify as business associates under the HIPAA Omnibus Rule. Your organization needs a business associate agreement (BAA) in place before sharing any data that touches patient information.

OCR has made clear through multiple enforcement actions that the absence of a BAA is one of the most commonly cited HIPAA violations. In 2024 alone, OCR continued to prioritize BAA compliance in its audit and investigation activities. Don't assume your Sunshine Act reporting vendor is outside HIPAA's reach simply because the final reports don't contain PHI.

Risk Analysis: Accounting for Sunshine Act Data Flows

Your HIPAA risk analysis under 45 CFR §164.308(a)(1)(ii)(A) should account for every system and workflow that touches PHI — including those connected to financial transparency reporting. Healthcare organizations consistently struggle with mapping data flows that cross departmental boundaries, and Sunshine Act compliance is a prime example.

Ask your compliance team these questions:

  • Do Sunshine Act reporting workflows share databases or file systems with clinical or billing data containing PHI?
  • Are workforce members involved in Open Payments reporting trained on HIPAA's minimum necessary standard?
  • Has your organization evaluated whether third-party reporting platforms meet Security Rule requirements for access controls and audit logging?
  • Do internal reports used for payment verification inadvertently include patient identifiers?

If you can't answer these questions with confidence, your risk analysis has a gap. Completing a thorough HIPAA training and certification program can help your compliance and finance teams identify exactly where these risks emerge.

Workforce Training That Bridges Both Compliance Frameworks

The HIPAA Security Rule requires workforce training at 45 CFR §164.308(a)(5). But most organizations train their workforce on HIPAA in isolation, completely disconnected from other regulatory obligations like the US Sunshine Act. This creates blind spots.

A physician relations coordinator who handles manufacturer payment data may not realize that cross-referencing a payment record with a clinical trial enrollment list creates a HIPAA exposure. A finance analyst pulling Sunshine Act reports from a shared drive may inadvertently access files containing protected health information. These aren't hypothetical scenarios — they reflect the day-to-day reality of healthcare administration.

Effective workforce training addresses these intersections head-on. Your training should cover not just the Privacy Rule and Security Rule in the abstract but how those rules apply to specific operational workflows, including financial transparency reporting. HIPAA Certify's workforce compliance platform provides the kind of practical, role-specific training that closes these gaps before they become violations.

OCR Enforcement and the Cost of Ignoring the Overlap

OCR hasn't issued enforcement actions specifically targeting Sunshine Act-related HIPAA breaches — yet. But the agency has repeatedly penalized organizations for failures that are directly relevant: inadequate risk analyses, missing business associate agreements, workforce access to PHI without authorization, and violations of the minimum necessary standard.

The penalty tiers under 45 CFR §160.404 range from $137 to $68,928 per violation, with annual caps reaching $2,067,813 per violation category (as adjusted for inflation). A single systemic failure — like giving your entire Sunshine Act reporting team unrestricted access to clinical databases — could trigger penalties across multiple categories.

Meanwhile, CMS enforces Sunshine Act reporting requirements independently. Your organization could face penalties from both CMS and OCR for different aspects of the same flawed workflow. That's a compliance risk that demands coordinated attention.

Three Steps to Align Sunshine Act and HIPAA Compliance Today

Bridging these two frameworks doesn't require a massive overhaul. Start with three practical steps:

  • Map your Sunshine Act data flows and identify every point where they intersect with systems containing PHI. Include this mapping in your next HIPAA risk analysis.
  • Review vendor relationships involved in Open Payments reporting. Execute or update business associate agreements where required.
  • Train cross-functional teams — finance, compliance, physician relations, research administration — on how HIPAA's minimum necessary standard and access controls apply to their Sunshine Act responsibilities.

The US Sunshine Act and HIPAA serve different purposes: one promotes financial transparency, the other protects patient privacy. But in your organization's daily operations, they share workflows, systems, and people. Managing them in silos is how violations happen. Managing them together is how compliance works.